Myriad Genetics
Price & Volume
Stats
See more52W Range | $9.36-$29.30 |
Market Cap | $911.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $837.6M |
Revenue Growth (YoY) | 7.1% |
Gross Profit (12 Mos) | $585.4M |
Diluted EPS | -$1.41 |
News
See moreYahoo Finance • 26 days ago
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
Yahoo Finance • 29 days ago
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth
Yahoo Finance • 29 days ago
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
Yahoo Finance • last month
Myriad Genetics Included in Forbes America’s Best Employers 2025 List
About
CEO | Mr. Paul J. Diaz J.D. |
Address | 322 North 2200 West, Salt Lake City, UT, United States, 84116 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 2,700 |
